Aktieselskabet Schouw & Co.
Schouw & Co. share buy-back programme, week 34 2025
Schouw & Co. share buy-back programme, week 34 2025
On 5 May 2025, Schouw & Co. initiated a share buy-back programme as outlined in Company Announcement no. 20 of 2 May 2025. Under the programme, Schouw & Co. will acquire shares for up to DKK 120 million during the period 5 May to 31 December 2025.
The buy-back will be structured in accordance with Regulation (EU) No. 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (MAR) and the Commission’s delegated regulation (EU) 2016/1052 of 8 March 2016 (“Safe Harbour” rules).
| Trading day | No. of shares | Average price | Amount | ||
| Accumulated until 15 August 2025 | 99,500 | 597.56 | 59,457,510 | ||
| Monday, 18 August 2025 | 2,000 | 582.18 | 1,164,360 | ||
| Tuesday, 19 August 2025 | 1,500 | 603.63 | 905,445 | ||
| Wednesday, 20 August 2025 | 1,500 | 600.17 | 900,255 | ||
| Thursday, 21 August 2025 | 1,500 | 597.75 | 896,625 | ||
| Friday, 22 August 2025 | 1,500 | 599.08 | 898,620 | ||
| In the period 18 August 2025 - 22 August 2025 | 8,000 | 595.66 | 4,765,305 | ||
| Accumulated until 22 August 2025 | 107,500 | 597.42 | 64,222,815 | ||
| Following the above transactions, Schouw & Co. holds a total of 2,149,493 treasury shares corresponding to 8.60% of the total share capital of 25,000,000 shares. | |||||
Aktieselskabet Schouw & Co.
Jørgen Dencker Wisborg, Chairman
Jens Bjerg Sørensen, President, telephone number +45 86 11 22 22
Attachments
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Oil-Dri Corporation Of America25.8.2025 22:00:00 CEST | Press release
Amlan® to Present on Biotoxin Control and Antibiotic-Free Poultry Production at Malaysia Livestock 2025
King Faisal Specialist Hospital & Research Centre25.8.2025 21:16:42 CEST | Press release
Over 2,000 Successful Surgeries for Drug-Resistant Epilepsy
F. Hoffmann-La Roche Ltd25.8.2025 20:30:00 CEST | Press release
Roche’s US subsidiary Genentech breaks ground on state-of-the-art manufacturing facility in North Carolina, USA
Recor Medical25.8.2025 18:21:49 CEST | Press release
Recor Medical Announces Paradise Ultrasound Renal Denervation System Receives Manufacturing and Marketing Approval in Japan for the Treatment of Resistant Hypertension
Vaisala Group25.8.2025 17:30:00 CEST | Press release
Vaisala Corporation: Share Repurchase 25.8.2025
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom